Meningoccal B vaccine

From WikiProjectMed
Jump to navigation Jump to search
Meningoccal B vaccine
Clinical data
WHO AWaReUnlinkedWikibase error: ⧼unlinkedwikibase-error-statements-entity-not-set⧽

Meningoccal B vaccine is a meningitis vaccine that protects against Neisseria meningitidis type B.[1] It is available as Bexsero (GlaxoSmithKline) and Trumenba (Pfizer).[2]

Of countries that have authorised MenB vaccines, not all have included it in a national vaccination policy.[3] Where available, the number of doses and the recommended schedule varies widely.[3] Unlike the MenACWY vaccine, MenB vaccination is not included in current immunization strategies for individuals entering the Kingdom of Saudi Arabia for Hajj and Umrah.[3]


  1. Suryadevara, Manika (2021). "19. Meningococcus". In Domachowske, Joseph; Suryadevara, Manika (eds.). Vaccines: A Clinical Overview and Practical Guide. Switzerland: Springer. pp. 235–246. ISBN 978-3-030-58416-0. Archived from the original on 2022-01-11. Retrieved 2022-06-13.
  2. Pollard, Andrew J.; Snape, Matthew D.; Sadarangani, Manish (2021). "22. Meningoccal vaccines". In Vesikari, Timo; Damme, Pierre Van (eds.). Pediatric Vaccines and Vaccinations: A European Textbook (Second ed.). Switzerland: Springer. pp. 254–255. ISBN 978-3-030-77172-0. Archived from the original on 2022-02-05. Retrieved 2022-06-13.
  3. 3.0 3.1 3.2 Sulis, Giorgia; Horn, Miranda; Borrow, Ray; Basta, Nicole E. (9 June 2022). "A comparison of national vaccination policies to prevent serogroup B meningococcal disease". Vaccine. 40 (26): 3647–3654. doi:10.1016/j.vaccine.2022.04.101. ISSN 1873-2518. Archived from the original on 14 June 2022. Retrieved 13 June 2022.